Telmisartan Nanosuspension for Inhaled Therapy of COVID-19 Lung Disease and Other Respiratory Infections.
Mol Pharm
; 20(1): 750-757, 2023 01 02.
Article
in En
| MEDLINE
| ID: mdl-36448927
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Respiratory Tract Infections
/
COVID-19
Limits:
Animals
Language:
En
Journal:
Mol Pharm
Journal subject:
BIOLOGIA MOLECULAR
/
FARMACIA
/
FARMACOLOGIA
Year:
2023
Type:
Article
Affiliation country:
United States